NCT04804306View on ClinicalTrials.gov

Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC

CompletedOBSERVATIONAL
Enrollment

198

Participants

Timeline

Start Date

September 5, 2021

Primary Completion Date

June 6, 2022

Study Completion Date

June 6, 2022

Conditions
SepsisAdult DiseaseEmergency DepartmentSevere Sepsis
Interventions
DEVICE

Diagnostic Test: CBC-DIFF Monocyte Volume Width Distribution (MDW)

MDW measurement used to detect sepsis. Results will not be used to manage patients.

Trial Locations (1)

07601

Hackensack University Medical Center, Hackensack

Sponsors
All Listed Sponsors
lead

Beckman Coulter, Inc.

INDUSTRY

NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC | Biotech Hunter | Biotech Hunter